AcelRx Pharmaceuticals, Inc. to Discuss the Phase 3 Top-Line Results - Conference Call

AcelRx Pharmaceuticals, Inc. to Discuss the Phase 3 Top-Line Results - Conference Call

Mar 5, 2013 from 8:30 AM to 8:30 AM EST

Live Teleconference Information

Primary # -
Secondary # -

866-605-3852 for Canadian callers